NSE BSE
supriya lifescience ltd stock

SUPRIYA LIFESCIENCE LTD Share Price

- - (%)
- NSE: SUPRIYA

SUPRIYA LIFESCIENCE LTD Share Price Update

As of the latest trading session, SUPRIYA LIFESCIENCE LTD share price is currently at 410.5, which is up by 10.79 from its previous closing. Today, the stock has fluctuated between 397.00 and 419.75. Over the past year, SUPRIYA LIFESCIENCE LTD has achieved a return of 62.67 %. In the last month alone, the return has been 0.50 %. Read More...

SUPRIYA LIFESCIENCE LTD Performance

Day Range

Low397.00 High419.75
410.50

52 Week Range

Low 233.30 High 424.70
410.50

SUPRIYA LIFESCIENCE LTD Share Price

7390

543434

SUPRIYA

img img img img
No Data Available

Open Price

400.80

Prev. Close

399.70

Volume (Shares)

759859.00

Total traded value

3119.22

Upper Circuit

479.60

Lower Circuit

319.80

Note: The current prices & values are delayed, Login to your account for live updates.

SUPRIYA LIFESCIENCE LTD Fundamentals


(Standalone)

Market Cap (Cr) 3303.80
PE Ratio (TTM) 27.00
Book Value / Share 101.30
Beta 0.62
ROE 13.67%
EPS (TTM) 14.80
Dividend Yield 0.20%
Net Profit Qtr (Cr) 36.93

SUPRIYA LIFESCIENCE LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 158.18
Operating Expense 107.19
Net Profit 36.93
Net Profit Margin (%) 23.34
Earnings Per Share (EPS) 4.59
EBITDA 57.69
Effective Tax Rate (%) 30.53
Particulars DEC 2023 (Values in Cr)
Revenue 140.07
Operating Expense 103.03
Net Profit 29.79
Net Profit Margin (%) 21.26
Earnings Per Share (EPS) 3.70
EBITDA 44.55
Effective Tax Rate (%) 25.71
Particulars SEP 2023 (Values in Cr)
Revenue 140.10
Operating Expense 112.77
Net Profit 23.88
Net Profit Margin (%) 17.04
Earnings Per Share (EPS) 2.97
EBITDA 34.22
Effective Tax Rate (%) 19.77
Particulars JUN 2023 (Values in Cr)
Revenue 132.02
Operating Expense 92.31
Net Profit 28.51
Net Profit Margin (%) 21.59
Earnings Per Share (EPS) 3.54
EBITDA 47.16
Effective Tax Rate (%) 33.13
Particulars MAR 2023 (Values in Cr)
Revenue 142.27
Operating Expense 90.94
Net Profit 38.23
Net Profit Margin (%) 26.87
Earnings Per Share (EPS) 4.75
EBITDA 57.01
Effective Tax Rate (%) 28.26
Particulars MAR 2024 (Values in Cr)
Revenue 570.37
Operating Expense 415.32
Net Profit 119.11
Net Profit Margin (%) 20.88
Earnings Per Share (EPS) 14.80
EBITDA 183.61
Effective Tax Rate (%) 28.11
Particulars MAR 2023 (Values in Cr)
Revenue 460.94
Operating Expense 346.94
Net Profit 89.86
Net Profit Margin (%) 19.49
Earnings Per Share (EPS) 11.16
EBITDA 138.39
Effective Tax Rate (%) 27.23
Particulars MAR 2022 (Values in Cr)
Revenue 530.05
Operating Expense 330.38
Net Profit 151.81
Net Profit Margin (%) 28.64
Earnings Per Share (EPS) 18.86
EBITDA 221.57
Effective Tax Rate (%) 26.75
Particulars MAR 2021 (Values in Cr)
Revenue 391.25
Operating Expense 228.91
Net Profit 123.59
Net Profit Margin (%) 31.58
Earnings Per Share (EPS) 16.89
EBITDA 178.15
Effective Tax Rate (%) 26.13
Particulars MAR 2020 (Values in Cr)
Revenue 311.64
Operating Expense 226.51
Net Profit 73.37
Net Profit Margin (%) 23.54
Earnings Per Share (EPS) 10.03
EBITDA 109.46
Effective Tax Rate (%) 23.72
Particulars MAR 2023 (Values in Cr)
Book Value / Share 86.91
ROE % 13.67
ROCE % 18.43
Total Debt to Total Equity 0.04
EBITDA Margin 26.79
Particulars MAR 2022 (Values in Cr)
Book Value / Share 76.50
ROE % 34.34
ROCE % 41.97
Total Debt to Total Equity 0.11
EBITDA Margin 37.65
Particulars MAR 2021 (Values in Cr)
Book Value / Share 36.70
ROE % 59.18
ROCE % 55.75
Total Debt to Total Equity 0.37
EBITDA Margin 41.34
Particulars MAR 2020 (Values in Cr)
Book Value / Share 101.84
ROE % 60.41
ROCE % 46.48
Total Debt to Total Equity 0.71
EBITDA Margin 35.12
Particulars MAR 2019 (Values in Cr)
Book Value / Share 12.82
ROE % 53.11
ROCE % 35.83
Total Debt to Total Equity 1.48
EBITDA Margin 22.65
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 157.58
Total Assets 820.27
Total Liabilities 820.27
Total Equity 699.45
Share Outstanding 80482800
Price to Book Ratio 2.19
Return on Assets (%) 10.95
Return on Capital (%) 12.55
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 227.90
Total Assets 734.76
Total Liabilities 734.76
Total Equity 615.68
Share Outstanding 80482800
Price to Book Ratio 6.44
Return on Assets (%) 20.66
Return on Capital (%) 23.83
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 89.27
Total Assets 445.46
Total Liabilities 445.46
Total Equity 268.58
Share Outstanding 73183530
Price to Book Ratio 0.00
Return on Assets (%) 27.74
Return on Capital (%) 36.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.54
Total Assets 336.15
Total Liabilities 336.15
Total Equity 149.07
Share Outstanding 14636706
Price to Book Ratio 0.00
Return on Assets (%) 21.82
Return on Capital (%) 32.15
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 1.73
Total Assets 253.05
Total Liabilities 253.05
Total Equity 93.79
Share Outstanding 14636706
Price to Book Ratio 0.00
Return on Assets (%) 15.57
Return on Capital (%) 22.01
Particulars MAR 2023 (Values in Cr)
Net Income 123.48
Cash from Operations 95.04
Cash from Investing -133.14
Cash from Financing -3.36
Net change in Cash -70.32
Free Cash Flow 203.48
Particulars MAR 2022 (Values in Cr)
Net Income 207.24
Cash from Operations 109.76
Cash from Investing -59.82
Cash from Financing 149.65
Net change in Cash 138.63
Free Cash Flow 169.66
Particulars MAR 2021 (Values in Cr)
Net Income 167.30
Cash from Operations 105.88
Cash from Investing -46.80
Cash from Financing -14.51
Net change in Cash 14.57
Free Cash Flow 154.12
Particulars MAR 2020 (Values in Cr)
Net Income 96.19
Cash from Operations 143.67
Cash from Investing -25.13
Cash from Financing -29.22
Net change in Cash 62.30
Free Cash Flow 168.81
Particulars MAR 2019 (Values in Cr)
Net Income 57.10
Cash from Operations 62.97
Cash from Investing 4.83
Cash from Financing -49.92
Net change in Cash 3.78
Free Cash Flow 69.92
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 116.00 12.68 1.25 1214.96 77.65 / 148.95
CIPLA LTD 1516.05 28.75 4.58 122423.77 1020.00 / 1581.70
FERMENTA BIOTECH LIMITED 200.05 0.00 2.03 588.77 136.60 / 219.05
GLAXOSMITHKLINE PHARMA LT 2552.80 65.86 24.32 43245.97 1376.50 / 2759.00
SANOFI INDIA LIMITED 6457.95 26.22 14.64 14872.66 5850.55 / 10526.05
Company Name Price P/E P/B Market Cap 52 Week Low/High
SUPRIYA LIFESCIENCE LTD 399.65 27.00 3.94 3216.50 231.05 / 424.80
AMRUTAJAN HEALTH LTD 744.70 47.86 7.46 2152.97 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6625.00 110.79 23.26 16562.50 3715.05 / 7550.00
BLISS GVS PHARMA LTD 116.00 15.96 1.22 1214.96 77.65 / 148.95
ABBOTT INDIA LIMITED 28590.80 50.58 16.42 60755.45 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 401.00
  • 26 Days 392.90
  • 10 Days 402.10
  • 50 Days 392.10
  • 12 Days 400.30
  • 100 Days 378.30
  • 20 Days 400.80
  • 200 Days 286.90
395.25
PIVOT
First Resistance 405.05
Second Resistance 410.40
Third Resistance 420.20
First Support 389.90
Second Support 380.10
Third Support 374.75
RSI 54.77
MACD 7.36
Commodity Channel Index (CCI) -52.69
ADX 46.19
Williams % R -55.93

Over 1 Month

down

0.50

Over 3 Months

down

9.92

Over 6 Months

down

28.43

Over 1 Year

down

62.67

Over 3 Years

down

0.74

Over 5 Years

down

0.00

SUPRIYA LIFESCIENCE LTD Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

SUPRIYA LIFESCIENCE LTD Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.62
Promoter Holdings
68.29
FII
4.94
DII
0.13
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Satish Waman Wagh Shareholding of Promoter and Promoter Group 5.4441205E7 67.64
Aditya Birla Sun Life Insurance Company Limited Public Shareholding 2905975.0 3.61
Cohesion Mk Best Ideas Sub-trust Public Shareholding 1603832.0 1.99
Hornbill Orchid India Fund Public Shareholding 1520000.0 1.89
Smita Satish Wagh Shareholding of Promoter and Promoter Group 321750.0 0.4
Shivani Satish Wagh Shareholding of Promoter and Promoter Group 102375.0 0.13
Saloni Satish Wagh Shareholding of Promoter and Promoter Group 102375.0 0.13
Satish Waman Wagh Partner Representing Supriyapharmaceuticals Shareholding of Promoter and Promoter Group 10.0 0.0
Arun Waman Wagh Shareholding of Promoter and Promoter Group 110.0 0.0

SUPRIYA LIFESCIENCE LTD

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2023-09-15 0.6 Final 2023-09-15 Equity shares 2022-09-01 0.6 Final 2022-09-02 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About SUPRIYA LIFESCIENCE LTD

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by SUPRIYA LIFESCIENCE LTD

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Supriya Lifescience Ltd?

Answer Field

The share price of Supriya Lifescience Ltd for NSE is ₹ 410.5 and for BSE is ₹ 411.1.

What is the Market Cap of Supriya Lifescience Ltd?

Answer Field

The market cap of Supriya Lifescience Ltd for NSE is ₹ 3,303.80 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Supriya Lifescience Ltd?

Answer Field

The 52 Week High and Low of Supriya Lifescience Ltd for NSE is ₹ 424.70 and ₹ 233.30 and for BSE is ₹ 424.80 and ₹ 231.05.

How to Buy Supriya Lifescience Ltd share?

Answer Field

You can trade in Supriya Lifescience Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Supriya Lifescience Ltd?

Answer Field

The 1 year returns on the stock has been 62.67%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader